MON-209 Perimenopause as a Vulnerable Period for Obesogenic Medications
Sara L Stockman(University of Pittsburgh Medical Center), Markella V. Zanni(Harvard University), Margot E. Manning(Massachusetts General Hospital)
Cited by 1
Related Papers
The Association of Obesity and Cardiometabolic Traits With Incident HFpEF and HFrEF
|JACC Heart Failure|2018|498
Pitavastatin to Prevent Cardiovascular Disease in HIV Infection
|New England Journal of Medicine|2023|476
Arterial Inflammation in Patients With HIV
|JAMA|2012|464
TNF-α Antagonism with Etanercept Decreases Glucose and Increases the Proportion of High Molecular Weight Adiponectin in Obese Subjects with Features of the Metabolic Syndrome
|The Journal of Clinical Endocrinology & Metabolism|2010|320
Sex Differences in Circulating Biomarkers of Cardiovascular Disease
|Journal of the American College of Cardiology|2019|160